Table 5.
Response |
Overall (Mean ± SD) |
CL (Mean ± SD) |
Non-CL (Mean ± SD) |
Meibomian gland dysfunction (n = 52) | 38.76 ± 10.33 | 36.49 ± 10.44 | 41.62 ± 9.66 |
No meibomian gland dysfunction (n = 229) | 28.50 ± 14.19 | 28.87 ± 14.40 | 28.09 ± 14.01 |
Positive and negative groups were significantly different for all conditions (all P values < 0.002). Rasch analysis was scaled to make all scores a maximum of 100.